Vertical HIV-1 transmission: Importance of neutralizing antibody titer and specificity

Scandinavian Journal of Immunology

Volumn 53, Issue 3, 2001, Pages 302-309

  Bongertz, V ^a   Costa, C I ^a   Veloso, V G ^b   Grinsztejn, B ^b   Joao Filho E C ^c   Calvet, G ^c   Pilotto, J H ^d   Guimaraes M L ^a   Morgado, M G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c Servidores Do Estado Hospital   (Brazil)

^d Nova Iguacu General Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MACROPHAGE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; SERODIAGNOSIS; VERTICAL TRANSMISSION; VIRUS ISOLATION; VIRUS TRANSMISSION;

ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0035120607     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00866.x     Document Type: Article

References (37)

1. The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels
2. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics
3. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
4. HIV-1 neutralizing antibodies: How full is the bottle?
5. Mother-to-child transmission of human immunodeficiency virus type I: Correlation with neutralizing antibodies against primary isolates
6. Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand
7. Lack of autologous neutralizing antibody to HIV-1 and macrophage tropism are associated with mother-to-infant transmission
8. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1
9. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain
10. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission
11. Mechanisms and timing of mother-to-child transmission of HIV-1
12. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes
13. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus
14. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the Women and Infants Transmission Study
15. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
16. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok
17. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype
18. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission
19. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission
20. Selection of maternal human immunodeficiency virus type 1 variants in human placenta
21. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy
22. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
23. Maternal viral lad, zidovudine treatment and risk of transmission of HIV-1 from mother to infant
24. Standard conditions of virus isolation reveal biological variability of HIV type I in different regions of the world
25. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
26. Neutralization susceptibility of B subtype variant B' primary HIV-1 isolates
27. Correlation between Susceptibility of primary HIV-1 isolates to Autologous and Heterologous Neutralizing Antibodies
28. Distinct replicative and cytopathic characteristics of HIV isolates
29. Anti-HIV-1 seroreactivity in distinct transmission risk groups
30. Genetic relationships determined by a DNA heteroduplex motility assay: Analysis of HIV-1 env genes
31. Molecular epidemiology of HIV in Brazil: High prevalence of B subtype and identification of a HIV-1 subtype D infection in Rio de Janeiro City
32. Reducing the risk of maternal-infant transmission of HIV by attacking the Virus
33. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers
34. Primary isolate neutralization by HIV-1 - Infected patient sera in the era of highly active antiretroviral therapy
35. Inhibition of immune functions by antiviral drugs
36. Is pregnancy immunosuppressive? Humoral immunity against viruses